Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: The Health in Men Study

International Journal of Epidemiology

Volumn 38, Issue 4, 2009, Pages 1049-1059

  Almeida, Osvaldo P ^a,b,c   Norman, Paul E ^b   Allcock, Richard ^b   van Bockxmeer, Frank ^b   Hankey, Graeme J ^c,d   Jamrozik, Konrad ^e   Flicker, Leon ^a,c,d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Affective disorder; Aged; Allostasis; C reactive protein; Depression; Depressive disorder; Elderly; Genetic polymorphism; Inflammation; Mood disorder

Indexed keywords

C REACTIVE PROTEIN; DNA;

DNA; GENETICS; GENOTYPE; MENS HEALTH; MORBIDITY; POLYMORPHISM; PROTEIN;

AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; COMMUNITY ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE PREDISPOSITION; DNA EXTRACTION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; GERIATRIC DEPRESSION SCALE; HEALTH SURVEY; HETEROZYGOSITY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SHORT FORM 36; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BODY MASS INDEX; C-REACTIVE PROTEIN; DEPRESSION; EPIDEMIOLOGIC METHODS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION MEDIATORS; LIFE STYLE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 68949129022     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyp199     Document Type: Article

References (43)

1. Kilpatrick JM, Volanakis JE. Molecular genetics, structure, and function of C-reactive protein. Immunol Res 1991;10:43-53.
2. Tillett WS, Francis T Jr. Serological reactions in pneumonia with a nonprotein somatic fraction of pneumococcus. J Exp Med 1930;52 561-85.
3. Morley JJ, Kushner I. Serum C-reactive protein levels in disease. Ann N Y Acad Sci 1982;389:406-18.
4. Volanakis JE. Human C-reactive protein: Expression, structure, and function. Mol Immunol 2001;38:189-97.
5. Robey FA, Jones KD, Steinberg AD. C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro. J Exp Med 1985;161:1344-56.
6. Kaplan MH, Volanakis JE. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J Immunol 1974;112:2135-47.
7. Volanakis JE, Kaplan MH. Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: Requirement for human C1q. J Immunol 1974; 113 9-17.
8. Marnell LL, Mold C, Volzer MA, Burlingame RW, Du Clos TW. C-reactive protein binds to Fc gamma RI in transfected COS cells. J Immunol 1995;155:2185-93.
9. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
10. Danesh J, Wheeler JG, Hirschfield GM et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.
11. Lawlor DA, Harbord RM, Timpson NJ et al. The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4,610 cases amongst 18,637 participants. PLoS ONE 2008;3:e3011.
12. Marsik C, Kazemi-Shirazi L, Schickbauer T et al. C-reactive protein and all-cause mortality in a large hospital-based cohort. Clin Chem 2008;54:343-49.
13. Vainas T, Lubbers T, Stassen FR et al. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation 2003;107 1103-1105.
14. Kravitz MS, Pitashny M, Shoenfeld Y. Protective molecules-C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity. J Clin Immunol 2005;25:582-91.
15. Gruenewald TL, Seeman TE, Ryff CD, Karlamangla AS, Singer BH. Combinations of biomarkers predictive of later life mortality. Proc Natl Acad Sci USA 2006;103:14158-63.
16. Ford DE, Erlinger TP. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2004;164: 1010-14.
17. Kop WJ, Gottdiener JS, Tangen CM et al. Inflammation and coagulation factors in persons>65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 2002;89:419-24.
18. Almeida OP, Norman P, Hankey GJ, Jamrozik K, Flicker L. The association between C-reactive protein concentration and depression in later life is due to poor physical health: Results from the Health in Men Study (HIMS). Psychol Med 2007;37:1775-86.
19. Fujii H, Li SH, Szmitko PE, Fedak PW, Verma S. C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2006;26:2476-82.
20. Davey Smith G, Ebrahim S, Lewis S, Hansell AL, Palmer LJ, Burton PR. Genetic epidemiology and public health: Hope, hype, and future prospects. Lancet 2005;366: 1484-98.
21. Brull DJ, Serrano N, Zito F et al. Human CRP gene polymorphism influences CRP levels: Implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 2003; 23:2063-69.
22. Crawford DC, Sanders CL, Qin X et al. Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 2006;114 2458-65.
23. Lange LA, Carlson CS, Hindorff LA et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 2006;296:2703-11.
24. Verzilli C, Shah T, Casas JP et al. Bayesian meta-analysis of genetic association studies with different sets of markers. Am J Hum Genet 2008;82:859-72.
25. Carlson CS, Aldred SF, Lee PK et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 2005; 77:64-77.
26. Norman PE, Flicker L, Almeida OP, Hankey GJ, Hyde Z, Jamrozik K. Cohort profile: The Health In Men Study (HIMS). Int J Epidemiol 2009; 38:48-52.
27. Almeida OP, Almeida SA. Short versions of the geriatric depression scale: A study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. Int J Geriatr Psychiatry 1999;14: 858-65.
28. Ware JE, Kosinski M, Gandek B. SF-36 Health Survey: Manual & Interpretation Guide. Lincoln, RI: QualityMetric Incorporated, 2000.
29. ABS. National Health Survey: SF-36 Population Norms. Australia: Australian Bureau of Statistics, Canberra, 1995.
30. Pearson TA, Mensah GA, Alexander RW et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
31. Timpson NJ, Lawlor DA, Harbord RM et al. C-reactive protein and its role in metabolic syndrome: Mendelian randomisation study. Lancet 2005;366:1954-59.
32. Almeida OP, Yeap BB, Hankey GJ, Jamrozik K, Flicker L. Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. Arch Gen Psychiatry 2008;65 283-89.
33. Russell AI, Cunninghame Graham DS, Shepherd C et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 2004; 13:137-47.
34. Strous RD, Shoenfeld Y. Behavioral changes in systemic lupus erythematosus are of an autoimmune nature. Nat Clin Pract Rheumatol 2007;3:592-93.
35. Katzav A, Solodeev I, Brodsky O et al. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum 2007; 56:938-48.
36. Lapteva L, Nowak M, Yarboro CH et al. Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum 2006;54:2505-14.
37. Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 2007;21:374-83.
38. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-56.
39. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998;338:171-79.
40. McEwen BS. Protective and damaging effects of stress mediators: Central role of the brain. Dialogues Clin Neurosci 2006;8:367-81.
41. Bisoendial RJ, Kastelein JJ, Peters SL et al. Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects. J Lipid Res 2007;48 952-60.
42. Birjmohun RS, Bisoendial RJ, van Leuven SI et al. A single bolus infusion of C-reactive protein increases gluconeogenesis and plasma glucose concentration in humans. Metabolism 2007;56:1576-82.
43. Penninx BW, Kritchevsky SB, Yaffe K et al. Inflammatory markers and depressed mood in older persons: Results from the Health, Aging and Body Composition study. Biol Psychiatry 2003;54:566-72.